The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Asthma Treatment Market Research Report 2025
Synopsis
Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and can make some physical activities difficult or even impossible.
Treatments for asthma fall into three primary categories: breathing exercises, rescue or first aid treatments, and long-term asthma control medications.
The global Asthma Treatment market was valued at US$ 21090 million in 2023 and is anticipated to reach US$ 23630 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Treatment.
Report Scope
The Asthma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
GSK
Novartis
Boehringer Ingelheim
Merck & Co. Inc
Roche Holdings Ltd
Sunovion Pharmaceuticals Inc
Schering-Plough Corp
Sanofi
Theravance Inc
Segment by Type
Breathing Exercises
Rescue/First Aid Treatments
Long-Term Asthma Control Medications
Monoclonal Antibody
Segment by Application
Mild Intermittent
Mild Persistent
Moderate Persistent
Severe Persistent
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and can make some physical activities difficult or even impossible.
Treatments for asthma fall into three primary categories: breathing exercises, rescue or first aid treatments, and long-term asthma control medications.
The global Asthma Treatment market was valued at US$ 21090 million in 2023 and is anticipated to reach US$ 23630 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Treatment.
Report Scope
The Asthma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
GSK
Novartis
Boehringer Ingelheim
Merck & Co. Inc
Roche Holdings Ltd
Sunovion Pharmaceuticals Inc
Schering-Plough Corp
Sanofi
Theravance Inc
Segment by Type
Breathing Exercises
Rescue/First Aid Treatments
Long-Term Asthma Control Medications
Monoclonal Antibody
Segment by Application
Mild Intermittent
Mild Persistent
Moderate Persistent
Severe Persistent
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Breathing Exercises
1.2.3 Rescue/First Aid Treatments
1.2.4 Long-Term Asthma Control Medications
1.2.5 Monoclonal Antibody
1.3 Market by Application
1.3.1 Global Asthma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mild Intermittent
1.3.3 Mild Persistent
1.3.4 Moderate Persistent
1.3.5 Severe Persistent
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Asthma Treatment Market Perspective (2019-2030)
2.2 Asthma Treatment Growth Trends by Region
2.2.1 Global Asthma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Asthma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Asthma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Asthma Treatment Market Dynamics
2.3.1 Asthma Treatment Industry Trends
2.3.2 Asthma Treatment Market Drivers
2.3.3 Asthma Treatment Market Challenges
2.3.4 Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Treatment Players by Revenue
3.1.1 Global Top Asthma Treatment Players by Revenue (2019-2024)
3.1.2 Global Asthma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Asthma Treatment Revenue
3.4 Global Asthma Treatment Market Concentration Ratio
3.4.1 Global Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Treatment Revenue in 2023
3.5 Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Asthma Treatment Product Solution and Service
3.7 Date of Enter into Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Treatment Breakdown Data by Type
4.1 Global Asthma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Asthma Treatment Forecasted Market Size by Type (2025-2030)
5 Asthma Treatment Breakdown Data by Application
5.1 Global Asthma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Asthma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Asthma Treatment Market Size (2019-2030)
6.2 North America Asthma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Asthma Treatment Market Size by Country (2019-2024)
6.4 North America Asthma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Asthma Treatment Market Size (2019-2030)
7.2 Europe Asthma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Asthma Treatment Market Size by Country (2019-2024)
7.4 Europe Asthma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Asthma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Asthma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Asthma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Asthma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Asthma Treatment Market Size (2019-2030)
9.2 Latin America Asthma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Asthma Treatment Market Size by Country (2019-2024)
9.4 Latin America Asthma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Asthma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Asthma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Asthma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Asthma Treatment Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Asthma Treatment Introduction
11.2.4 GSK Revenue in Asthma Treatment Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Asthma Treatment Introduction
11.3.4 Novartis Revenue in Asthma Treatment Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Asthma Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Asthma Treatment Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Merck & Co. Inc
11.5.1 Merck & Co. Inc Company Detail
11.5.2 Merck & Co. Inc Business Overview
11.5.3 Merck & Co. Inc Asthma Treatment Introduction
11.5.4 Merck & Co. Inc Revenue in Asthma Treatment Business (2019-2024)
11.5.5 Merck & Co. Inc Recent Development
11.6 Roche Holdings Ltd
11.6.1 Roche Holdings Ltd Company Detail
11.6.2 Roche Holdings Ltd Business Overview
11.6.3 Roche Holdings Ltd Asthma Treatment Introduction
11.6.4 Roche Holdings Ltd Revenue in Asthma Treatment Business (2019-2024)
11.6.5 Roche Holdings Ltd Recent Development
11.7 Sunovion Pharmaceuticals Inc
11.7.1 Sunovion Pharmaceuticals Inc Company Detail
11.7.2 Sunovion Pharmaceuticals Inc Business Overview
11.7.3 Sunovion Pharmaceuticals Inc Asthma Treatment Introduction
11.7.4 Sunovion Pharmaceuticals Inc Revenue in Asthma Treatment Business (2019-2024)
11.7.5 Sunovion Pharmaceuticals Inc Recent Development
11.8 Schering-Plough Corp
11.8.1 Schering-Plough Corp Company Detail
11.8.2 Schering-Plough Corp Business Overview
11.8.3 Schering-Plough Corp Asthma Treatment Introduction
11.8.4 Schering-Plough Corp Revenue in Asthma Treatment Business (2019-2024)
11.8.5 Schering-Plough Corp Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Asthma Treatment Introduction
11.9.4 Sanofi Revenue in Asthma Treatment Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Theravance Inc
11.10.1 Theravance Inc Company Detail
11.10.2 Theravance Inc Business Overview
11.10.3 Theravance Inc Asthma Treatment Introduction
11.10.4 Theravance Inc Revenue in Asthma Treatment Business (2019-2024)
11.10.5 Theravance Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
